These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32550547)

  • 1. Upregulation of the long non-coding RNA CBR3-AS1 predicts tumor prognosis and contributes to breast cancer progression.
    Xu L; Zhu H; Gao F; Tang Y; Zhu Y; Sun Z; Wang J
    Gene X; 2019 Jun; 2():100014. PubMed ID: 32550547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the long non-coding RNA CBR3-AS1 predicts tumor prognosis and contributes to breast cancer progression.
    Xu L; Zhu H; Gao F; Tang Y; Zhu Y; Sun Z; Wang J
    Gene; 2019; 721S():100014. PubMed ID: 34530987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
    Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.
    Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway.
    Cai Y; Huang Y; Zhang J; Liu X; Zhao F; Zhang K; Xu S; Yang Y; Huang H; Gao Y
    Neoplasma; 2022 Dec; 69(6):1406-1417. PubMed ID: 36591804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Zhang Y; Meng W; Cui H
    Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion.
    Hou M; Wu N; Yao L
    Cancer Cell Int; 2021 Jan; 21(1):36. PubMed ID: 33422081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA CBR3-AS1 Promotes Stem-like Properties and Oxaliplatin Resistance of Colorectal Cancer by Sponging miR-145-5p.
    Xie L; Cui G; Li T
    J Oncol; 2022; 2022():2260211. PubMed ID: 35466320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1.
    Cao J; Zhao Q; Jia Q; Li Y
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):181-186. PubMed ID: 37715388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimetazidine Alleviates Bleomycin-Induced Pulmonary Fibrosis by Targeting the Long Noncoding RNA CBR3-AS1-Mediated miRNA-29 and Resistin-Like Molecule alpha 1: Deciphering a Novel Trifecta Role of LncRNA CBR3-AS1/miRNA-29/FIZZ1 Axis in Lung Fibrosis.
    Alzahrani AR; Mohamed DI; Abo Nahas HH; Alaa El-Din Aly El-Waseef D; Altamimi AS; Youssef IH; Ibrahim IAA; Mohamed SMY; Sabry YG; Falemban AH; Elhawary NA; Bamagous GA; Jaremko M; Saied EM
    Drug Des Devel Ther; 2024; 18():3959-3986. PubMed ID: 39252766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-coding RNA CBR3 Antisense RNA 1 is Downregulated in Colorectal Cancer and Inhibits miR-29a-Mediated Cell Migration and Invasion.
    Yang M; Chen W; Liu H; Yu L; Tang M; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):773-779. PubMed ID: 35107754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 /miR-409-3p/SOD1 axis.
    Liu S; Zhan N; Gao C; Xu P; Wang H; Wang S; Piao S; Jing S
    Cancer Lett; 2022 Feb; 526():1-11. PubMed ID: 34801596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.
    Zhang Y; Zhang H; Zhang X; Liu B
    Dis Markers; 2022; 2022():7155525. PubMed ID: 35655916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway.
    Yao W; Hou J; Liu G; Wu F; Yan Q; Guo L; Wang C
    Mol Ther Oncolytics; 2022 Jun; 25():189-200. PubMed ID: 35592388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
    Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
    J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression.
    Huang L; Dai G
    Bioengineered; 2022 Jan; 13(1):12-26. PubMed ID: 34967274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.